GGrantIndex
Sort

11,323 grants matching glioblastoma

Deciphering the role of pH regulator Slc4a4 in glioma progression

$134,582
Qi Ye · Baylor College Of Medicine · K99 · FY2024 · CA

Deciphering the role of pH regulator Slc4a4 in glioma progression

$134,582
Qi Ye · Baylor College Of Medicine · K99 · FY2025 · CA

Multivalent Inhibition of Membrane Receptors

$134,529
Stewart Durell · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Comprehensive Identification of bivalent promoters in Brain Tumor Stem Cells

$134,200
Gregory D Foltz · Swedish Medical Center, First Hill · R21 · FY2010 · CA

Mechanisms of subtelomere recombination in telomerase deficient tumors

$134,115
Tammy A Morrish · University Of Toledo Health Sci Campus · R00 · FY2014 · CA

NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM

$134,083
Massachusetts General Hospital · U01 · FY2003 · CA

6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study

$134,044
Mustafa Khasraw · Duke University · U19 · FY2023 · CA

Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors

$133,942
Ningling Kang · Mayo Clinic Rochester · K01 · FY2009 · CA

Histone Modification and GBM Therapy

$133,829
Joseph C Loftus · Mayo Clinic Rochester · P50 · FY2014 · CA

Development of Mouse Astrocytoma Model for Preclinical Testing

$133,716
Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Clinical Studies to Circumvent Drug Resistance

$133,716
Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma

$133,687
Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2024 · CA

Malignant Gliomas Biorepository Core

$133,615
Ichiro Nakano · Ohio State University · P01 · FY2014 · CA

Administration and neuropathology oversight

$133,613
Fred H Hochberg · Massachusetts General Hospital · P01 · FY2012 · CA

TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM

$133,603
Duke University · P50 · FY2004 · CA

Mitochondrial transfer from astrocytes to glioblastoma cells drives tumor growth

$133,514
Dionysios C Watson · University Of Miami School Of Medicine · R00 · FY2025 · CA

TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM

$133,469
Duke University · P50 · FY2005 · CA

TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM

$133,465
Henry S. Friedman · Duke University · P50 · FY2006 · CA

MDM2 inhibitor therapy for TP53 wild-type GBM

$133,307
Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2025 · CA

BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma

$133,280
Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2017 · CA

Credentialing murine models for glioblastoma preclinical drug development

$133,154
Christopher Ryan Miller · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

Potent Topoisomerase I Inhibition For Glioma Therapy

$133,125
Tigen Pharmaceuticals · R41 · FY2001 · CA

DEVELOPMENT OF A TOXIC FUSION PROTEIN FOR BRAIN TUMORS

$133,067
Neurocrine Biosciences, Inc. · R43 · FY2000 · CA

Core 2: Glioblastoma Biorepository Core

$133,022
Keith L Ligon · Brigham And Women'S Hospital · P01 · FY2025 · CA

Microglia promote dispersal of glioma cells through Pyk2 intracellular signaling

$132,982
Lilia Kucheryavykh · Universidad Central Del Caribe · SC2 · FY2014 · GM